Detalhe da pesquisa
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587254
2.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 790-802, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351721
3.
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.
Arterioscler Thromb Vasc Biol
; 43(8): 1572-1582, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381988
4.
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
Circulation
; 145(3): 158-169, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743554
5.
Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.
Circulation
; 146(14): 1067-1081, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082663
6.
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
Circulation
; 145(21): 1581-1591, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35510542
7.
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
Eur Heart J
; 43(41): 4362-4373, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900838
8.
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
N Engl J Med
; 381(14): 1309-1320, 2019 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31475798
9.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med
; 381(21): 1995-2008, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31535829
10.
Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.
Am Heart J
; 246: 136-143, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986394
11.
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial.
Am Heart J
; 251: 1-12, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533724
12.
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
Eur Heart J
; 42(31): 3011-3020, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34080008
13.
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF.
Circulation
; 141(2): 100-111, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736328
14.
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
Circulation
; 141(2): 90-99, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736335
15.
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF.
Circulation
; 142(17): 1623-1632, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883108
16.
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
Lancet
; 396(10266): 1895-1904, 2020 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33197395
17.
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
Eur Heart J
; 41(17): 1625-1632, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811715
18.
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Circulation
; 139(22): 2516-2527, 2019 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30882239
19.
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
N Engl J Med
; 376(20): 1933-1942, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514624
20.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
N Engl J Med
; 376(16): 1527-1539, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28304242